February 24, 2025
Most of us know mosquitoes primarily as unwelcome summer guests, but these tiny insects possess extraordinary sensory abilities that could inspire tomorrow’s technology.
Next-gen disaster detection technology inspired by mosquito hearing
February 22, 2025
Phosphorus-31 magnetic resonance spectroscopic imaging (31P-MRSI) provides valuable non-invasivein vivoinformation on tissue metabolism but is burdened by poor sensitivity and prolonged scan duration.
Feasibility and comparison of 3D modified rosette ultra-short echo time (PETALUTE) with conventional weighted acquisition in 31P-MRSI
February 22, 2025
Researchers at Purdue have developed a computational program called NuFold to model 3D RNA structures.
February 20, 2025
One of nature's most disliked creatures may very well unlock a breakthrough in disaster response. A multidisciplinary research team is recreating mosquito antennae to better study their sensitivity to vibrations.
How mosquitoes hear may inspire new ways to detect natural disasters
February 20, 2025
Purdue University professor Ximena Bernal studies how natural enemies shape animal communication systems, focusing on mosquitoes that eavesdrop on frogs.
February 19, 2025
Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk
Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk
February 19, 2025
Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, more accurate detection of challenging diseases, starting with pancreatic cancer, has received regulatory clearance under the federal Clinical Laboratory Improvement Amendments (CLIA) program for its first product, PanCystPro™.
Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk
February 18, 2025
Amplified Sciences, a clinical-stage life sciences diagnostic company that develops tests for early, more accurate detection of challenging diseases, starting with pancreatic cancer, has received regulatory clearance under the federal Clinical Laboratory Improvement Amendments (CLIA) program for its first product, PanCystPro™.
Amplified Sciences earns CLIA certification for its first test to assess pancreatic cancer risk
February 18, 2025
A West Lafayette-based life sciences diagnostic company has received federal regulatory clearance for its first product aimed at early detection of pancreatic cancer.
Amplified Sciences earns key clearance for cancer diagnostic test
February 18, 2025
Augmented living equipped with electronic devices requires widespread connectivity and a low-loss communication medium for humans to interact with ambient technologies.
Human-structure and human-structure-human interaction in electro-quasistatic regime
